HALO logo
halo search icon
ImmuPharma plc

GBP0.048

Price Change Indicator
0.0023 (5.09%)
ImmuPharma plc
IMM · LON

ImmuPharma plc

Start Trading IMM for Free

GBP0.048

Price Arrow0.0023 (5.09%)
20/05/2026 12:00:00 AM
All-CompaniesBig CandleConsensus ExpensiveHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ImmuPharma plc Overview

IMM Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About IMM

icon
icon

Telephone

44.20.7206.2650

icon

Address

One Bartholomew Close, London, Greater London EC1A 7BL

Description

ImmuPharma Plc engages in the research, development, and commercialization of pharmaceutical products. It is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The firm's portfolio consists of four novel peptide therapy areas: autoimmunity, metabolism, cancer and anti-infectives. Its drug Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F. Dimitriou in 1999 and is headquartered in London, the United Kingdom.

IMM Price Chart

Key Stats

Market Cap

GBP29.64M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.19

Trade Value (12mth)

US$134,357.00

1 week

8.45%

1 month

3.26%

YTD

-23.39%

1 year

65.79%

All time high

1.94

Key Fundamentals

EPS 3 yr Growth

-81.50%

EBITDA Margin

0.00%

Operating Cashflow

-£2m

Free Cash Flow Return

-687.50%

ROIC

-967.40%

Interest Coverage

NaN

Quick Ratio

0.60

Other Data

Shares Outstanding (Fully Diluted)

480m

HALO Sector

Healthcare

Next Company Report Date

26-May-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

GBP

Short Sell (% of issue)

0.00

IMM Announcements

Latest Announcements

DateAnnouncements
05 May 26
10 April 26
09 April 26
07 April 26
27 March 26

IMM Fundamentals

Per Share Records

Historical data

Forecast data

GBP2020202120222023202220232024202520262027
Per Share, Growth & Valuations
EPS (Basic)
 £locklocklocklock-0.01-0.01-0.01locklocklock
EPS (Fully Diluted)
 £locklocklocklock-0.01-0.01-0.01locklocklock
Growth
 %locklocklocklock61.235.725.9locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of ImmuPharma plc (IMM:LON)?
Halo FAQ
The current share price of ImmuPharma plc (IMM:LON) is GBP£0.05.
What is the 52-week high share price for ImmuPharma plc (IMM:LON)?
Halo FAQ
The 52-week high share price for ImmuPharma plc (IMM:LON) is GBP£0.19.
What is the 52-week low share price for ImmuPharma plc (IMM:LON)?
Halo FAQ
The 52-week low share price for ImmuPharma plc (IMM:LON) is GBP£0.01.
What is the dividend yield for ImmuPharma plc (IMM:LON)?
Halo FAQ
ImmuPharma plc (IMM:LON) does not pay a dividend.
What was ImmuPharma plc (IMM:LON) last dividend payment?
Halo FAQ
ImmuPharma plc (IMM:LON) does not pay a dividend.
What is the franking level for ImmuPharma plc (IMM:LON)?
Halo FAQ
ImmuPharma plc (IMM:LON) has a franking level of 0.00%.
In which sector is ImmuPharma plc (IMM:LON) classified?
Halo FAQ
ImmuPharma plc (IMM:LON) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial